サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433430

世界のマルチオミクス市場：2023-2030年

Global Multiomics Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 205 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
世界のマルチオミクス市場：2023-2030年
出版日: 2023年12月27日
発行: Orion Market Research
ページ情報: 英文 205 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマルチオミクス市場は、予測期間（2024-2031年）に16.5%というかなりのCAGRで成長すると予測されています。マルチオミクス技術の進歩は、いくつかの疾患の治療への応用の拡大とともに、世界市場の成長を促進する重要な要因となっています。マルチオミクスの新たな応用分野の発見は、市場の成長をさらに後押ししています。2023年3月、調査チームは子宮筋層を含むヒト-母体-胎児界面全体の空間分解マルチオミクスシングルチセルアトラスを作成し、妊娠初期における絨毛細胞分化の全軌跡を解明することを可能にしました。

シングルセル・ゲノミクスに対する研究者の関心の高まりが、市場の成長にさらに寄与しています。国立医学図書館が2023年3月に発表した調査結果によると、シングルセル・ゲノミクスは心血管障害の研究分野で数多くの応用が可能であることが判明しています。心臓の発達、心筋梗塞、心臓再灌流障害、動脈硬化、心房細動、心肥大、心不全などに活用できます。

この市場の可能性を見据えて、新しい新興企業がベンチャーキャピタルから資金を得てこの分野に参入しています。2023年12月、COMPASSプラットフォームの開発者であるPepper Bioは、NFX、Merck Digital Sciences Studio、Mana Ventures、Silverton Partners、Tensility Ventures、VSC Ventures などの参加を得て、650万米ドルのシード・ラウンドを実施したと発表しました。この資金調達により、Pepper Bioのトランスオミクス・プラットフォーム機能が加速され、パイプラインが充実しています。

セグメント別の展望

世界のマルチオミクス市場において、サービスセグメントがかなりのCAGRを示すと予想されます。

数多くのマルチオミクスサービスに対する需要の高まりにより、市場企業はいくつかのサービスを市場に投入するようになりました。新製品の発売は、この市場セグメントの成長を促進する重要な要因です。2023年9月、マルチオミクスCROのPsomagen社は、10X Genomics Xenium向けの空間生物学サービスを開始しました。このプラットフォームは空間生物学を再形成し、世界中の研究者が遺伝子とタンパク質の相互作用を本来の組織の文脈の中で解析できるようにします。これは、科学界が空間ゲノミクスにアクセスする上で極めて重要です。さらに、2021年4月、Mission Bioはファーマ・アッセイ開発（PAD）サービスを開始しました。これにより、ユーザーは、がん領域における創薬、翻訳、臨床研究において、シングルセル・マルチオミクス機能を導入することができるようになります。

地域別展望

世界のマルチオミクス市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。アジア太平洋地域は、世界市場でかなりの成長を示すと予想されています。同地域の製薬会社がゲノミクスの研究開発に関心を高めていることが、同地域の市場成長を促進する主な要因となっています。

北米が世界市場で大きなシェアを占める

同地域の市場シェアを牽引しているのは、複数の主要市場プレイヤーの存在により、ゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクスの分野で同地域全体で高い研究開発活動が行われていることです。さらに、この分野への投資と政府の取り組みが増加していることも、この地域の市場シェアの高さに寄与しています。例えば、2023年11月、テキサスA&M大学システムは、ゲノム、栄養、健康の複雑なつながりを研究する学際的共同研究のために、国立衛生研究所（NIH）から119万米ドルの助成金を得ました。これらのつながりを理解することは、がんやその他の病気の診断や治療に役立つと思われます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Bio Rad Laboratories, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific, Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Mission Bio, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • マルチオミクスの世界市場：製品・サービス別
    • 製品
      • 装置
      • 消耗品
      • ソフトウェア
    • サービス
  • マルチオミクスの世界市場：タイプ別
    • シングルセルマルチオミクス
    • バルクマルチオミクス
  • マルチオミクスの世界市場：用途別
    • 細胞生物学
    • 腫瘍学
    • 神経学
    • 免疫学
  • マルチオミクスの世界市場：エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 学術・研究機関
    • 病院・診断研究所

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • 10x Genomics, Inc.
  • Becton, Dickinson and Company
  • Berkeley Lights Inc
  • BGI Genomics Co. Ltd
  • Danaher Corp（Cytiva Life Sciences）
  • Dolomite Bio
  • Epicypher Inc.
  • Fluidigm Corp
  • Illumina, Inc
  • Miltenyi Biotec B.V. & CO.
  • Nanostring Technologies, Inc
  • Olink Holding AB（Olink Proteomics）
  • Parse Bioscience
  • Qiagen N.V.
  • Takara Holdings Inc. Takara Bio Group
図表

LIST OF TABLES

  • 1. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
  • 2. GLOBAL MULTIOMICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3. GLOBAL MULTIOMICS SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 5. GLOBAL SINGLE-CELL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 6. GLOBAL BULK MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 7. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 8. GLOBAL MULTIOMICS FOR CELL BIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9. GLOBAL MULTIOMICS FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 10. GLOBAL MULTIOMICS FOR IMMUNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 11. GLOBAL MULTIOMICS FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 12. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 13. GLOBAL MULTIOMICS FOR PHARMA & BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 14. GLOBAL MULTIOMICS FOR ACADEMICS & RESEARCH ORGANIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 15. GLOBAL MULTIOMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 16. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 17. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 18. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
  • 19. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 20. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 21. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 22. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 23. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
  • 24. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 25. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 26. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 27. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 28. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
  • 29. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 30. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 31. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
  • 32. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 33. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
  • 34. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
  • 35. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
  • 36. REST OF THE WORLD TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023 VS 2031 (%)
  • 2. GLOBAL MULTIOMICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 3. GLOBAL MULTIOMICS SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 4. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023 VS 2031 (%)
  • 5. GLOBAL SINGLE-CELL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 6. GLOBAL BULK MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 7. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023 VS 2031 (%)
  • 8. GLOBAL MULTIOMICS FOR CELL BIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 9. GLOBAL MULTIOMICS FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 10. GLOBAL MULTIOMICS FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 11. GLOBAL MULTIOMICS FOR IMMUNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 12. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023 VS 2031 (%)
  • 13. GLOBAL MULTIOMICS FOR PHARMA & BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 14. GLOBAL MULTIOMICS FOR ACADEMICS & RESEARCH ORGANIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 15. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 16. US MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 17. CANADA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 18. UK MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 19. FRANCE MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 20. GERMANY MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 21. ITALY MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 22. SPAIN MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 23. REST OF EUROPE MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 24. INDIA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 25. CHINA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 26. JAPAN MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 27. SOUTH KOREA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
  • 29. REST OF THEWORLD MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
目次
Product Code: OMR2028082

Global Multiomics Market Size, Share & Trends Analysis Report by Product & Services (Product and Services), by Type (Single-cell Multiomics and Bulk Multiomics), by Application (Cell Biology, Oncology, Neurology, and Immunology), by End-User (Pharma & Biotech Companies, Academics & Research Organization, and Hospital & Diagnostic Laboratories), Forecast Period (2024-2031)

The global multiomics market is anticipated to grow at a considerable CAGR of 16.5% during the forecast period (2024-2031). Advancements in multiomics technology along with its growing application in the treatment of several disorders is a key factor driving the growth of the global market. The discovery of new application areas of multiomics is further aiding the market growth. In March 2023, the researchers generated a spatially resolved multiomics single-cell atlas of the entire human-maternal-fetal interface including the myometrium, which enables them to resolve the full trajectory of trophoblast differentiation during the first trimester of pregnancy.

The growing interest of researchers in single-cell genomics is further contributing to the market growth. As per the research published by the National Library of Medicine in March 2023, single-cell genomics is found to have numerous applications in the field of cardiovascular disorder research. It can be utilized in heart development, Myocardial Infarction, Cardiac reperfusion injury, atherosclerosis, atrial fibrillation, cardiac hypertrophy, and heart failure.

Looking towards the potential of this market, new startups are entering into this field with funding from venture capitalists. In December 2023, Pepper Bio developer of the COMPASS platform announced an oversubscribed $6.5 million seed round with participation from NFX, Merck Digital Sciences Studio, Mana Ventures, Silverton Partners, Tensility Ventures, VSC Ventures, and others. This funding will accelerate Pepper Bio's transomics platform capabilities, fueling the pipeline.

Segmental Outlook

The global multiomics market is segmented based on product & services, type, application, and end-user. Based on products & services, the market is segmented into products & services. Product is further sub-segmented into instruments, consumables, and software. Based on type, the market is segmented into single-cell multiomics and bulk multiomics. Based on application, the market is segmented into cell biology, oncology, neurology, and immunology. Based on end-user, the market is segmented into

Service Segment is Anticipated to Exhibit Considerable CAGR in the Global Multiomics Market

The growing demand for numerous multiomics services has promoted market players to launch several services in the market. New product launches are a key factor driving the growth of this market segment. In September 2023, Multiomics CRO Psomagen launched Spatial Biology services for 10X Genomics Xenium. This platform is reshaping spatial biology, enabling researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. This marks a pivotal moment in the scientific community's access to spatial genomics. Further, in April 2021, Mission Bio launched its Pharma Assay Development (PAD) service, enabling its customers to obtain early access services based on the newest technologies as well as on its existing products. This will support users to implement single-cell multiomics capabilities in their drug discovery, translation, and clinical research endeavors in oncology.

Regional Outlook

The global multiomics market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market. The growing interest of regional pharmaceutical companies in the R&D of genomics is a key factor driving the regional market growth.

North America Held Considerable Share in the Global Market

The regional market share is driven by the high R&D activities across the region in the fields of genomics, transcriptomics, proteomics, and metabolomics owing to the presence of several key market players. Additionally, increasing investment and government initiatives in this field are also contributing to the high share of the regional market. For instance, in November 2023, The Texas A&M University System received a $1.19 million grant from the National Institutes of Health (NIH) for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition, and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.

Market Players Outlook

The major companies serving the global multiomics market include Bio Rad Laboratories, Inc., Thermo Fischer Scientific Inc., Mission Bio, Inc., Danaher Corp., and Illumina among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their software offerings to stay competitive in the market. For instance, in April 2023, Bio-Techne entered a strategic partnership with Lunaphore for the development of a fully automated spatial multiomics solution. Under the partnership, the companies will engage in the development of the first fully automated spatial multiomics workflow for same-slide hyperplex detection of protein and RNA biomarkers. The new solution is expected to offer ultimate flexibility in panel design. It will support researchers to easily incorporate antibodies with RNAscope in situ hybridization probes to highlight changes in cell phenotypes and functional states across different diseases.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global multiomics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Bio Rad Laboratories, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Thermo Fisher Scientific, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Mission Bio, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Multiomics Market by Products & Services
    • 4.1.1. Products
      • 4.1.1.1. Instruments
      • 4.1.1.2. Consumables
      • 4.1.1.3. Software
    • 4.1.2. Services
  • 4.2. Global Multiomics Market by Type
    • 4.2.1. Single-Cell Multiomics
    • 4.2.2. Bulk Multiomics
  • 4.3. Global Multiomics Market by Application
    • 4.3.1. Cell Biology
    • 4.3.2. Oncology
    • 4.3.3. Neurology
    • 4.3.4. Immunology
  • 4.4. Global Multiomics Market by End-User
    • 4.4.1. Pharma & Biotech Companies
    • 4.4.2. Academics & Research Organization
    • 4.4.3. Hospital and Diagnostic Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
        • 5.4.0.5.3.5. Rest of Asia-Pacific
      • 5.5.5.4. Rest of the World

6. Company Profiles

  • 6.1. 10x Genomics, Inc.
  • 6.2. Becton, Dickinson and Company
  • 6.3. Berkeley Lights Inc
  • 6.4. BGI Genomics Co. Ltd
  • 6.5. Danaher Corp (Cytiva Life Sciences)
  • 6.6. Dolomite Bio
  • 6.7. Epicypher Inc.
  • 6.8. Fluidigm Corp
  • 6.9. Illumina, Inc
  • 6.10. Miltenyi Biotec B.V. & CO.
  • 6.11. Nanostring Technologies, Inc
  • 6.12. Olink Holding AB (Olink Proteomics)
  • 6.13. Parse Bioscience
  • 6.14. Qiagen N.V.
  • 6.15. Takara Holdings Inc. Takara Bio Group